The evolving continuum of dysglycaemia: Non-diabetic hyperglycaemia in older adults

Identifying non-diabetic hyperglycaemia (NDH) and intervening to halt the progression to type 2 diabetes has become an essential component of cardiovascular and cerebrovascular risk reduction. Diabetes prevention programs have been instigated to address the increasing prevalence of NDH and type 2 di...

Full description

Saved in:
Bibliographic Details
Published in:Diabetic medicine 2023-10, Vol.40 (10), p.e15177-e15177
Main Authors: Golding, J, Hope, S V, Chakera, A J, Puttanna, A
Format: Article
Language:English
Subjects:
Cardiovascular diseases
Diabetes
Diabetes mellitus (non-insulin dependent)
Diagnosis
Hyperglycemia
Older people
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Identifying non-diabetic hyperglycaemia (NDH) and intervening to halt the progression to type 2 diabetes has become an essential component of cardiovascular and cerebrovascular risk reduction. Diabetes prevention programs have been instigated to address the increasing prevalence of NDH and type 2 diabetes by targeting lifestyle modifications. Evidence suggests that the risk of progression from NDH to type 2 diabetes declines with age, and that a diagnosis of type 2 diabetes in older adults is not associated with the same risk of adverse consequences as it is in younger age groups. The current definition of NDH is not adjusted based on a person's age. Therefore, there is debate about the emphasis that should be placed upon a diagnosis of NDH in older adults. This article will explore the evidence and current clinical practice surrounding dysglycaemia through the spectrum of different age ranges, and the potential implications this has for older adults.
ISSN:0742-3071
1464-5491
DOI:10.1111/dme.15177